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FEBS Open Bio 1 (2011) 14journal homepage: www.elsevier .com/locate / febsopenbioNote from the Society and PublisherFEBS together with Elsevier are delighted to announce the
launch of FEBS OPENBIO, an open access, author-pays journal.
The journal is dedicated to publishing articles across the molecular
and cellular life sciences in both health and disease.
FEBS and Elsevier recognise the clear importance of peer review
to evaluate the quality of scientiﬁc research and have established a
distinguished Editorial Board to judge submissions. The aim will be
to publish thoroughly sound analysis and experimental ﬁndings for
the beneﬁt of all researchers.
In launching this new journal, FEBS aims to meet the growing
interest in open access publishing and invites direct submissions
of novel ﬁndings. It will also be open to the transfer of articles
submitted to existing FEBS publications (FEBS Letters, FEBS Journal
and Molecular Oncology) which have been judged as sound and adoi:10.1016/j.fob.2011.10.001contribution to knowledge but not to meet the criteria set by the
editors for publication in these journals: these manuscripts can
proceed with their original reviewer reports without the need to
resubmit or reformat the manuscript.
Many distinguished members of the Editorial Boards of FEBS’
journals have joined the Editorial Board of FEBS OPENBIO to sup-
port this new initiative.
We look forward to receiving your support for this initiative, we
welcome your feedback and suggestions, and look forward to
receiving your papers.
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